Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism

D Armanini, M Boscaro, L Bordin… - International journal of …, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is a heterogeneous and extremely common disease with
symptoms that vary with the age of the patient, typically characterized by hyperandrogenism …

[HTML][HTML] Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention

O Osibogun, O Ogunmoroti, ED Michos - Trends in cardiovascular …, 2020 - Elsevier
Although polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders
affecting women, its etiology is not entirely understood. Clinical symptoms of PCOS include …

Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences

P Anagnostis, BC Tarlatzis, RP Kauffman - Metabolism, 2018 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …

Epidemiology, diagnosis, and management of polycystic ovary syndrome

SM Sirmans, KA Pate - Clinical epidemiology, 2013 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common heterogeneous endocrine disorder
characterized by irregular menses, hyperandrogenism, and polycystic ovaries. The …

The role of chronic inflammation in polycystic ovarian syndrome—a systematic review and meta-analysis

S Aboeldalyl, C James, E Seyam, EM Ibrahim… - International journal of …, 2021 - mdpi.com
Although the current literature associates polycystic ovarian syndrome (PCOS) with chronic
inflammation, the evidence for this link remains inconclusive and its causal nature remains …

[HTML][HTML] Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

HF Escobar-Morreale, M Luque-Ramírez, F González - Fertility and sterility, 2011 - Elsevier
OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …

Cardiometabolic aspects of the polycystic ovary syndrome

HS Randeva, BK Tan, MO Weickert, K Lois… - Endocrine …, 2012 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women
of reproductive age and is associated with various metabolic perturbations, in addition to …

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

S Palomba, A Falbo, F Zullo, F Orio Jr - Endocrine reviews, 2009 - academic.oup.com
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome

KA Toulis, DG Goulis, G Mintziori… - Human reproduction …, 2011 - academic.oup.com
BACKGROUND The relation between polycystic ovary syndrome (PCOS) and
cardiovascular disease (CVD) remains unclear. In an attempt to provide high-quality …

[HTML][HTML] Cardio-metabolic disease and polycystic ovarian syndrome (PCOS): a narrative review

SL Sangaraju, D Yepez, XA Grandes, RT Manjunatha… - Cureus, 2022 - ncbi.nlm.nih.gov
Polycystic ovarian syndrome (PCOS) is considered the most common endocrine disorder
affecting females in today's world. Although it has been primarily studied and discussed in …